跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIVAROXABAN-TEVA FC TABLET 10MG - HSA Drug Approval Details
Approvals
/
HSA
/
RIVAROXABAN-TEVA FC TABLET 10MG
Approved
THERAPEUTIC
RIVAROXABAN-TEVA FC TABLET 10MG
Teva Pharmaceutical Industries, Ltd. (ISRAEL)
🇸🇬 Health Sciences Authority
Approval Date
Feb 2, 2026
Approval ID
4b0e4175e457c3ec
Company
Teva Pharmaceutical Industries, Ltd. (ISRAEL)
Type
Therapeutic
Approval Details
Approval Id
4b0e4175e457c3ec
Drug Name
RIVAROXABAN-TEVA FC TABLET 10MG
Product Name
RIVAROXABAN-TEVA FC TABLET 10MG
Approval Number
SIN17450P
Approval Date
2026-02-02
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 2, 2026
Approval ID
4b0e4175e457c3ec
Type
Therapeutic
Back to HSA Approvals